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A B S T R A C T
The accumulation of vascular smooth muscle (SMC)-like cells and stem cell-derived myogenic and osteogenic
progeny contributes significantly to arteriosclerotic disease. This study established whether label-free vibrational
spectroscopy can discriminate de-differentiated ‘synthetic’ SMCs from undifferentiated stem cells and their
myogenic and osteogenic progeny in vitro, compared with conventional immunocytochemical and genetic
analyses. TGF-β1- and Jagged1-induced myogenic differentiation of CD44+ mesenchymal stem cells was con-
firmed in vitro by immunocytochemical analysis of specific SMC differentiation marker expression (α-actin,
calponin and myosin heavy chain 11), an epigenetic histone mark (H3K4me2) at the myosin heavy chain 11
locus, promoter transactivation and mRNA transcript levels. Osteogenic differentiation was confirmed by ali-
zarin red staining of calcium deposition. Fourier Transform Infrared (FTIR) maps facilitated initial screening and
discrimination while Raman spectroscopy of individual cell nuclei revealed specific spectral signatures of each
cell type in vitro, using Principal Components Analysis (PCA). PCA fed Linear Discriminant Analysis (LDA) en-
abled quantification of this discrimination and the sensitivity and specificity value was determined for all cell
populations based on a leave-one-out cross validation method and revealed that de-differentiated SMCs and
stem-cell derived myogenic progeny in culture shared the greatest similarity. FTIR and Raman spectroscopy
discriminated undifferentiated stem cells from both their myogenic and osteogenic progeny. The ability to detect
stem cell-derived myogenic progeny using label-free platforms in situ may facilitate interrogation of these im-
portant phenotypes during vascular disease progression.
1. Introduction
Cardiovascular diseases (CVD), such as arteriosclerosis, in-stent
restenosis and pulmonary hypertension (PAH), remain a leading cause
of global death and result from pathologic arterial remodelling [1,2]. A
hallmark of arterial remodelling is intimal medial thickening (IMT) due
to the accumulation of vascular smooth muscle (SMC)-like cells within
the intima leading to the obstruction of blood flow and resulting in a
heart attack or stroke [3]. The source of these neointimal cells includes
stem cell-derived myogenic progeny (St-SMCs) [4–7] and SMCs fol-
lowing endothelial-mesenchymal transition (EndMT) [4,8] in addition
to de-differentiation and reprogramming of SMCs (ddSMCs) [9].
Transforming growth factor (TGF)-β1 and Notch ligands (Jagged1) are
both putative regulators of stem cell myogenic differentiation in vitro
[10,11] and may contribute to stem cell myogenic differentiation and
SMC accumulation during arterial remodelling in vivo [6,12,13].
Therefore, early detection of de-differentiated SMCs and/or stem cell-
derived progeny (following myogenic differentiation) by these factors
as a source of neointimal cells during early stages of disease and its
progression by means a novel photonic interrogation system would be
highly desirable.
Amongst the various imaging platforms available to interrogate
closely related cell populations and discriminate cell-dependent
changes in vessel structure due to arteriosclerosis, label-free techniques
such as vibrational spectroscopy have shown great promise [14]. Vi-
brational spectroscopy is a subset of spectroscopy which analyses
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vibrations within a molecule (or material), which are characteristic of
the molecular structure and, in polyatomic molecules, give rise to a
spectroscopic “fingerprint” of that molecule. The spectrum of vibra-
tional energies can thus be employed to characterise a molecular
structure, or changes to it due to the local environment or external
factors (e.g. radiation, chemical agents). Vibrational energies fall within
the mid - Infrared (IR) region of the electromagnetic spectrum and are
commonly probed through IR absorption spectroscopy [15]. Raman
spectroscopy is a complementary technique whereby incident radiation
couples with the oscillating polarisation of the molecule and thus
generates or annihilates a vibrational quantum, similarly resulting in a
vibrational spectrum [16]. The differing underlying mechanisms give
rise to a complementarity of the two techniques, such that vibrations of
asymmetric, polar bonds tend to be strong in IR spectra, whereas
Raman is particularly suitable as a probe of symmetric, nonpolar
groups. Moreover, FTIR monitors the absorption of IR radiation
whereas Raman scattering can be employed in the UV, visible or near-
IR regions of the spectrum and thus offers intrinsically higher spatial
resolution for cellular and subcellular mapping or profiling. The limit of
resolution is determined classically by the wavelength (< 1 μm for
Raman, ~5-10 μm for IR) [17]. Therefore, the longer wavelength of
mid infrared radiation, coupled with the use of multidetector arrays in
the Fourier Transform mode, render IR techniques more suitable for
mapping larger cell populations or tissue sections [18].
The current study was undertaken to establish whether vibrational
spectroscopy could be implemented as a novel photonic platform to
discriminate undifferentiated bone marrow-derived stem cells from
their myogenic progeny following differentiation in vitro and further
whether these cell populations could be discriminated from de-differ-
entiated ‘synthetic’ SMCs and stem cell-derived osteogenic progeny.
2. Methods
2.1. Materials
Unless otherwise stated, all chemicals and reagents were obtained
from Sigma-Aldrich and were of the highest purity commercially
available (Sigma-Aldrich, Ireland). A more detailed version of the
Methods is presented in the Appendix A.
2.2. Cell culture
Freshly isolated vascular SMC were grown up to passage 4 in culture
in RPMI-1640 supplemented with 10% FCS, as previously described
[19] and were deemed proliferative de-differentiated “synthetic” SMCs
(ddSMCs). Sprague-Dawley rat mesenchymal stem cells (bm-MSC) were
purchased from Gibco (S1601-100) and cultured as per the manufac-
turer's instructions. These rat bm-MSCs have been validated previously
as multipotent stem cells that have a large capacity for self-renewal
while maintaining their multipotency [20,21]. Importantly, this cell
population expresses all the common MSC markers and is able to dif-
ferentiate into the three lineages recapitulating a ‘true’ mesenchymal
cell phenotype http://tools.thermofisher.com/content/sfs/manuals/
GIBCO_Rat_(SD)_MSCs.pdf). Myogenic and osteogenic differentiation
of bm-MSC was established following culture of cells in DMEM sup-
plemented with TGF-β1 (R&D, 7666-MB-005) (St-SMC-TGF-β1), re-
combinant Jagged1-Fc (R&D, 599-JG) (St-SMC-Jag-1) for 14 days and
StemPro® Osteogenic Differentiation Kit (ThermoFisher, USA,
A1007201) for 21 days, respectively.
2.3. Immunocytochemistry
Fixed cells were incubated overnight at 4 °C with primary anti-
bodies at the appropriate dilution washed and further incubated with
the secondary antibody (Biosciences, anti-goat A-11055, anti-rabbit
A11008) at a dilution of 1:1000 for 1 h at room temperature. An
Olympus CK30 microscope with Cell^F software was used to capture
images. At least five images from the Olympus CK30 microscopy per
experimental group (minimum n = 3) were analysed using ImageJ
software as previously described [20,21].
2.4. Realtime qRT-PCR
Quantitative real-time RT-PCR was performed using the Rotor Gene
(RG-3000, Corbett Research) and a Quantitect™ Primer assay system
using Quantitect rat primers (Qiagen, Manchester UK) as previously
described [20]. Gene expression was normalised to that of the house-
keeping gene, hypoxanthine-guanine phosphoribosyltransferase
(HPRT).
2.5. Chromatin immunoprecipitation assay (ChIP assay)
Cells were cross-linked and DNA was sheared to 500–1000 bp by
sonication before ChIP analysis was carried out using the MAGnify™
Chromatin Immunoprecipitation System (InVitrogen, Bioscience
Ireland, cat no 49-2024) according to the manufacturer's instruction.
Recovered DNA was analysed by qPCR. The ChIP-qPCR data was nor-
malised for sources of variability, including amount of chromatin, ef-
ficiency of immunoprecipitation, and DNA recovery using the Fold
Enrichment Method. This normalisation method is also called ‘signal
over background’ or ‘relative to the no-antibody control’. With this
method, the ChIP signals are divided by the no-antibody signals, re-
presenting the ChIP signal as the fold increase in signal relative to the
background signal. The assumption of this method is that the level of
background signal is reproducible between different primer sets, sam-
ples, and replicate experiments. All samples were performed in tripli-
cate from at least three independent experiments.
2.6. Myh11-promoter luciferase assay
Cells were transiently transfected with Myh11 reporter plasmid
(Myh11-GLuc, GeneCopoeia, Inc. Cat No; MPRM16957-PG02) and
Renilla reporter plasmid (Promega, Madison, WI) for 24 h using
TransIT-X2® Dynamic Delivery System (Mirus Bio, Madison, WI) in
OptiMEM according to the manufacturer's instruction. Gaussia luci-
ferase activities were normalised to the activity of internal control
Renilla luciferase activities using the dual luciferase assay system de-
scribed by the manufacturer (Promega, Madison, WI). All assays were
performed in triplicate.
2.7. Sample preparation for spectroscopic analysis
For both FTIR and Raman spectroscopic analyses, cells were seeded
on calcium fluoride slides in 6 well plates at approximately 10,000
cells/well. After fixation, the slides were washed with PBS and placed
briefly in distilled water. The slides were left to air dry before recording
spectra.
2.8. FTIR spectroscopy
IR absorption measurements were carried out using a Perkin Elmer
Spotlight 400 N FTIR imaging system. The system was equipped with
an AutoImage microscope system operating with a ×40 Cassegrain
objective and operates in transmission or reflection mode. FTIR images
were acquired in transmission mode with 10 scans of a 150 × 150 μm
area of the slide for each cell population. All experiments were carried
out in triplicate (576 spectra per scan were recorded, 30 scans per
sample, ~15,000 spectra per cell population). Individual spectra were
acquired with a liquid nitrogen cooled mercury cadmium telluride
(MCT-A) line detector of pixel size 6.25 μm × 6.25 μm at a spectral
resolution of 4 cm−1, interferometer speed of 1.0 cm/s and the useable
spectral range is restricted to 900–4000 cm−1. Background
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measurements were acquired on a region with no cells with 120 scan-
s per pixel whereas 32 scans per pixel were recorded from the sample.
2.9. Raman spectroscopy
Raman spectra were recorded using a custom-built Raman micro-
spectroscopy system, as previously described [22,23]. Briefly, this
system employed a 150 mW laser with a wavelength of 532 nm (Laser
Quantum, Torus), spectrograph (Andor, Shamrock 500) operating with
600 lines/mm grating, and a CCD camera (Andor; DU420A-BR-DD)
cooled to −80 °C. A 50× microscope objective (MO), with numerical
aperture of 0.8 (Olympus, UMPlanFl), was used to image the spectral
irradiance to a 100 μm confocal aperture, which isolates the signal from
the cell nucleus, and minimises background noise from the sample
substrate, as well as from optical elements in the system [22,23].
2.10. Data processing and analysis
The different data pre-processing and analysis steps were performed
using Matlab (Mathworks, USA). For FTIR data, the resonant Mie
scattering correction algorithm (RMieS-EMSC) was employed to re-
move scattering effects from FTIR spectra [24], as has been successfully
demonstrated in a number of studies [25]. For Raman data, cosmic ray
removal is followed by application of an extended multiplicative signal
correction (EMSC) algorithm as described in detail previously [23].
After pre-processing, Principal Components Analysis (PCA) was em-
ployed as an unsupervised multivariate analysis tool to differentiate the
data recorded from different cell phenotypes.
2.11. Statistical analysis
All biochemical analysis experiments were performed in triplicate
and data are presented as mean ± SEM for at least three independent
runs. Statistical analysis was performed with Prism v6 software package
using t-test for parametric data or a Wilcoxon Signed Rank test for non-
parametric data.
3. Results
3.1. FTIR and Raman spectroscopy both discriminate bone-marrow derived
mesenchymal stem cells from their osteogenic progeny in vitro
A sample population of CD44+ bm-MSCs was analysed by both FTIR
and Raman spectroscopy, and the raw spectra recorded, processed and
the mean spectrum presented [Fig. 1]. The FTIR bands are labelled with
assignments of typical biochemical origin. In the “high wavenumber
region”, > 2500 cm−1, the distinctive vibrations of NeH, CeH and
OeH of lipids and proteins can be found, whereas in the “fingerprint
region”, < 2000 cm−1, the features are typically more complex com-
binations, including the Amide I (1650 cm−1) and Amide II
(1520 cm−1) modes of proteins, nucleic acid phosphate stretching
modes at 1070 cm−1 and 1250 cm−1 and lipidic derived features at
1310 cm−1 and 1750 cm−1. A more detailed list of band assignments is
provided in Table 1. Mean Raman spectra for bm-MSC nuclei were also
recorded and analysed following cosmic ray removal and EMSC cor-
rection. The prominent peaks in bm-MSCs are annotated and presented
in Fig. 1(b), Table 2. It should be noted that, although complementary
techniques, the features in the respective spectra of FTIR and Raman
have similar origin. Thus, the Raman spectrum of the nucleus exhibits
similarly prominent signatures associated with proteins and lipids
across the fingerprint region, as well as large peaks related to DNA and
RNA at 785 cm−1.
Osteogenic differentiation of bm-MSC to osteogenic progeny (St-
Osteo) was first validated by phase contrast microscopy of gross mor-
phological differences before and after osteogenic differentiation. St-
Osteo cells were morphologically distinct from bm-MSC and exhibited a
more osteoblast phenotype with a pronounced, large spherical nucleus
[Fig. 2a(ii–iii)]. Alizarin red staining confirmed the presence of calcium
deposits in St-Osteo when compared to bm-MSC [Fig. 2a(iv–v)], pro-
viding evidence for bm-MSC multipotency in vitro. Osteogenic differ-
entiation of bm-MSC to St-Osteo was analysed by FTIR spectroscopy
and a spectrally integrated IR map of a representative population of bm-
MSC is presented [Fig. 2a(vi)]. There were notable differences in the St-
Osteo mean spectra across the high wavenumber (2000-3500 cm−1)
and fingerprint (1000–1800 cm−1) regions [Fig. 2b], in particular, a
strong feature at ~1037 cm−1 that overlapped the nucleic acid phos-
phate backbone band at ~1070 cm−1 that is commonly assigned to
carbonate groups in apatite [26]. There were also notable differences at
2964 cm−1 (corresponding to CH3 asymmetric stretching of lipids and
proteins) where St-Osteo cells had a greater peak intensity. The loading
of the discriminating PC1 demonstrated pronounced increases in the
feature at 1037 cm−1 for St-Osteo and a reduction of the strong Amide I
and Amide III features at 1220–1280 cm−1 [Fig. 2b]. PCA identified all
significant changes across the FTIR spectroscopic datasets and the
scatter plots generated clearly discriminated both groups from each
Fig. 1. (a). Representative mean FTIR spectra recorded for bm-MSCs following Resonant
Mie (RMieS) correction with classification of relevant peaks and their known association
to proteins, nucleic acid and lipids described in Table 1. (b) Processed mean Raman
spectra for bm-MSCs following cosmic ray removal and EMSC correction and their known
association to proteins, nucleic acid and lipids are described in Table 2.
Table 1
Peak assignments for FTIR spectra data.
Wavenumber FTIR peak assignments Association
(i) 1036 CeC skeletal stretching Proteins
(ii) 1072 PO2 symmetric stretching DNA/RNA
(iii) 1152 CeC and CeO stretching Proteins
(iv) 1220–1280 PO2 asymmetric stretching
Amide III
DNA/RNA
(v) 1312 CH2 stretching Phospholipids
(vi) 1400 CH3 symmetric stretching Proteins
(vii) 1456 CH3 asymmetric stretching Proteins
(viii) 1546 Amide II Proteins
(ix) 1620–1700 Amide I Proteins
(x) 1742 Ester, C]O stretching Lipids
(xi) 2854 CH2 symmetric stretching Lipids
(xii) 2926 CH2 asymmetric stretching Lipids
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other [Fig. 2c].
Raman spectra of individual cell nuclei from bm-MSC and St-Osteo
were also recorded and the mean spectra are superimposed to reveal
clear differences [Fig. 2d]. The most pronounced was the peak at
960 cm−1, clearly indicating the presence of phosphates associated
with mineralisation within the St-Osteo cells [Fig. 2d] [27]. Prominent
bands at 1030 cm−1 and 1070 cm−1 associated with phosphate and
carbonate groups respectively, were also evident although they were
very much weaker compared to the prominent 960 cm−1 feature.
Several other peaks were observed that clearly separated bm-MSC from
their osteogenic progeny and relate to nucleic acid (DNA/RNA) at
788 cm−1, 1338 cm−1, 1490 cm−1, and 1585 cm−1 as well as lipids at
1379 cm−1 [Fig. 2d]. PCA identified significant changes across the
spectrum and the scatter plots generated clearly discriminated both
groups from each other [Fig. 2e].
3.2. FTIR and Raman spectroscopy discriminates bone-marrow derived
mesenchymal stem cells from their myogenic progeny in vitro
Myogenic differentiation following treatment of bm-MSC with TGF-
β1 was confirmed by determining the enrichment of a synonymous SMC
epigenetic histone signature at the myosin heavy chain 11 (Myh11)
promoter, Myh11 promoter transactivation, SMC differentiation marker
transcript levels (Myh11, CNN1) and immunocytochemical detection of
the number of Myh11 and CNN1 cells, respectively [Fig. 3]. Chromatin
immunoprecipitation (ChIP) analysis of freshly isolated rat aortic SMCs
confirmed the enrichment of the specific SMC epigenetic mark, di-me-
thylation of lysine 4 on histone H3 (H3K4me2) at the Myh11 locus [28]
concomitant with a lack of enrichment of the tri-methylation of lysine
27 on histone H3 (H3K27me3) mark which is consistent with a general
repression of developmental genes [29] [Fig. 3a]. In contrast, bm-MSC
were enriched for the H3K27me3 mark at the same locus [Fig. 3a].
Treatment of bm-MSC with TGF-β1 (2 ng/ml) for 7 d increased the level
of enrichment of the H3K4me2 mark with a reciprocal diminution of
the H3K27me3 mark to levels that were comparable to H3K4me2 and
H3K27me3 levels in sub-cultured de-differentiated rat SMCs (ddSMCs)
[Fig. 3a]. TGF-β1 treatment also significantly induced Myh11-promoter
transactivation [Fig. 3b] after 2 d concomitant with enhanced Myh11
mRNA levels [Fig. 3c]. Furthermore, treatment of bm-MSCs with TGF-
β1 (2 ng/ml) for 14 d resulted in a marked increase in the number of
Myh11+ and calponin-1 (CNN1+) positive cells, when compared to
vehicle control [Fig. 3d]. Similarly, treatment of bm-MSC with Jag-1-Fc
resulted in a significant increase in Myh11 and CNN1 mRNA levels after
48 h [Fig. 3e] concomitant with a dramatic increase in the number of
smooth muscle cell α-actin (SMA+) and CNN1+ positive cells after 7 d
[Fig. 3f].
FTIR maps and mean spectra were recorded for bm-MSC and their
myogenic progeny [Fig. 3g]. In both cases, there were significant peak
intensity differences in myogenic progeny in the high wavenumber
region,> 2500 cm−1, in particular, between 2800 cm−1 and
3000 cm−1 [Fig. 3 g] which is associated with acyl chain stretching
vibrations from fatty acids of lipids [30]. There were also significant
spectral differences in bands in the CeH stretching region associated
with absorbance from lipids (3050-2800 cm−1), the amide I and II re-
gion associated with protein absorbance (1700–1500 cm−1), and in the
lower wavenumber region associated with nucleic acids
(1300–1000 cm−1) [Fig. 3g]. Notably, PCA of the FTIR spectroscopic
data demonstrated that bm-MSCs could be clearly separated from their
myogenic progeny according to the first principal component (PC1)
[Fig. 3h]. Moreover, 3-way multivariate statistical analysis revealed
that bm-MSC could be clearly discriminated from their myogenic pro-
geny, independent of the inductive stimulus to generate the progeny
[Fig. 3h].
3.3. FTIR spectroscopic comparisons between de-differentiated SMC, MSCs
and stem cell derived myogenic progeny
Morphological analysis of dissociated rat aortic SMC grown in cul-
ture up to passage 4 (ddSMCs) exhibited strong cytoplasmic re-
fractivity, an oval nucleus and rich cytoplasm and overlapped when
confluent, forming typical SMC ‘peak-to-valley’ growth, as previously
reported [31]. The two major morphological phenotypes were ‘spindle
shaped’ and ‘epithelioid’ [Fig. 4a]. In contrast, the majority of myogenic
progeny [St-SMC-TGF-β1] were spindle-like cells without a strong cy-
toplasmic refractivity [Fig. 4a]. The levels of SMA and Myh11 protein
and Myh11 mRNA transcripts were significantly reduced in ddSMC
when compared to freshly isolated rat aortic SMCs and were compar-
able to the levels present in stem cell-derived myogenic progeny [St-
SMC-TGF-β1] [Fig. 4b, c].
FTIR maps and mean spectra were recorded and analysed for
ddSMCs and compared to both undifferentiated bm-MSCs and their
myogenic (St-SMC-TGF-β1) and osteogenic progeny (St-Osteo), re-
spectively [Fig. 4d], before PCA analysis of the spectroscopic datasets
was performed [Fig. 4e]. Prominent peaks were observed for ddSMCs
across the high wavenumber (2000-3500 cm−1) and fingerprint (1000-
1800 cm−1) regions of the spectrum. In particular, the main spectral
characteristics were bands at ~1540 cm−1 and 1650 cm−1 (amide I
and II, respectively), ~1060 cm−1, 1225 cm−1 and 1460 cm−1 (CeC
and CeH bending) and ~2850 cm−1–2960 cm−1 and 3325 cm−1. The
peak at ~1225 cm−1, associated with phosphate stretching modes, was
noticeably reduced in both ddSMC and St-Osteo cells, when compared
undifferentiated bm-MSC and their myogenic progeny [Fig. 4d], re-
spectively, as were the peaks at 1380 cm−1 and 1660 cm−1 (associated
with amide I and II proteins) and 2850–2960 cm−1 (associated with
distinctive vibrations of NeH, CeH and OeH of lipids and proteins)
[Fig. 4d]. In contrast, the ddSMC had a more prominent peak at the
~1036 cm−1 and ddSMC and St-Osteo cells at ~3296 cm−1 that are
associated with proteins [Table 1 [Fig. 4d].
Using 4-way multivariate statistical analysis, there was a significant
separation of the four populations by FTIR [Fig. 4e, Table 3] as it
successfully discriminated ddSMCs, undifferentiated bm-MSCs and
their myogenic (St-SMC-TGF-β1) or osteogenic (St-Osteo) progeny.
Moreover, using PCA/LDA, FTIR could discriminate between un-
differentiated bm-MSCs from both their myogenic and osteogenic pro-
geny (St-Osteo) with significant confidence even when these daughter
cells originated from the same undifferentiated bm-MSC stem cell po-
pulation [Table 3].
Table 2
Peak assignments for Raman spectra data.
Wavenumber Chemical bond Association
(i) 785–788 Stretching of DNA related bonds, and
DNA/RNA breathing modes
Nucleic acid
(ii) 1004 Phenylalanine Protein
(iii) 1090 Stretching of DNA related bonds Nucleic acid
Stretching of CeN backbone Protein
(iv) 1127 Stretching of CeN backbone Protein
Stretching of CeC Lipid
(v) 1262 DNA/RNA breathing modes Nucleic acid
Amide III Lipid
(vi) 1319 CH2, CH3 twisting Lipid
DNA/RNA breathing modes Nucleic acid
CH deformation vibration Protein
(vii) 1341 DNA/RNA breathing modes Nucleic acid
CH deformation vibration Protein
(viii) 1451 CH2 deformation vibration Protein/lipid
(ix) 1585 DNA/RNA breathing modes Nucleic acid
(x) 1619 Tyrosine; tryptophan Protein
(xi) 1662 DNA/RNA breathing modes Nucleic acid
Amide I Protein
Fatty acids Lipid
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3.4. Raman spectroscopic comparisons between de-differentiated SMC,
MSCs and stem cell derived SMC progeny
All four cell populations were separated by multivariate statistical
analysis of Raman spectra [Fig. 4f] using a 4-way PCA scatterplot
[Fig. 4g, Table 4] with the most notable differences apparent for the St-
Osteo spectra [Fig. 4f]. Peak intensities were higher at the
785–788 cm−1 and 1585 cm−1 correlating to nucleic acids, 960 cm−1
corresponding to its strong phosphate peak and the 1375 cm−1 asso-
ciated with proteoglycans [32]. Many other prominent wavenumbers in
the loadings for the first two principal components are also highlighted
and the wavenumber associations are discussed below [Fig. 4f].
Using PCA/LDA, Raman spectroscopy discriminated un-
differentiated bm-MSCs from both their myogenic (St-SMC-TGF-β1) and
osteogenic (St-Osteo) progeny with significant confidence even when
these daughter cells originated from the same undifferentiated bm-MSC
stem cell population [Table 4].
When the Raman spectra for bm-MSC and their myogenic progeny
(St-SMC-TGF-β1) were compared [Fig. 5a], there was a clear separation
across both of the first two components [Fig. 5b]. Analysis of the pro-
minent spectral features in both PC1 and PC2 for these cells revealed
significant spectral differences relating to nucleic acid (DNA/RNA) at
788 cm−1, 1090 cm−1, 1262 cm−1, 1338 cm−1, 1373 cm−1,
1490 cm−1, and 1581 cm−1; proteins at 1004 cm−1, 1053 cm−1 and
1614–1619 cm−1; and lipids at 1262 cm−1, 1300 cm−1, 1379 cm−1,
1439–1454 cm−1 and 1650 cm−1–1695 cm−1, respectively [Fig. 5a].
When the Raman spectra for ddSMC were compared to bm-MSC
[Fig. 5c], there was a clear separation across only the first component
Fig. 2. (a) (i) Representative immunocytochemical image of CD44+ bm-MSC in culture, (ii–iii) phase contrast images and (iv, v) alizarin red staining of bm-MSCs before and after
osteogenic differentiation with osteogenic inductive media for 21 d, (vi) representative FTIR heat map of bm-MSCs. (b) Mean FTIR spectra and loading plot of the first principal
component and (c) PCA score plot of the bm-MSCs (black) and the St-Osteo (green) cell groups before and after osteogenic differentiation. (d) Mean Raman spectra and loading plot of the
first principle component following PCA of the processed bm-MSC and St-Osteo datasets and (e) PCA score plot of bm-MSCs and St-Osteo before and after osteogenic differentiation.
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[Fig. 5d], and the loading for only this component is shown [Fig. 5c].
Many of the spectral differences recorded for bm-MSC versus St-SMCs
(TGF-β1) were also observed when ddSMC were compared bm-MSC
[Fig. 5c]. In addition to sharing these peaks, more peaks were observed
in PC1 that relate to nucleic acid at 813 cm−1 and 1420 cm−1; proteins
at 1031 cm−1; and lipids at 1220–1250 cm−1, 1420 cm−1 and
1554 cm−1.
In contrast, when the Raman spectra of ddSMC were compared to
St-SMC (TGF-β1), there were significant similarities between both
spectra with sharp bands at the 1004 cm−1, 1262 cm−1, 1319 cm−1,
1585 cm−1 and 1662 cm−1 [Fig. 5e]. Some differences were observed
at 788 cm−1, 1319 cm−1 and 1585 cm−1, corresponding to nucleic
acid content, indicative of differences between the DNA/RNA content
of the St-SMCs (TGF-β1) and the ddSMCs [Fig. 5e]. Further differences
were observed in the region of 1262 cm−1 attributable to the nucleic
acid guanine and amide III and at 1619 cm−1 attributable to tyrosine or
tryptophan [Fig. 5e]. Raman spectra of ddSMCs were further compared
to St-Osteo and revealed significant differences in the spectra of these
two populations, consistent primarily with the onset of mineralization
[data not shown]. Finally, PCA analysis of Raman spectra could not
directly separate the St-SMCs (TGF-β1) and ddSMC groups with 100%
accuracy [Fig. 5f]. However, classification of both cell populations was
achieved using a combination of PCA and LDA when applied to each of
the four experimental groups. The ddSMC were classified correctly with
89.7% sensitivity and the St-SMC (TGF-β1) correctly with a 92.7%
sensitivity on a leave-one-out cross validation method (Table 4).
4. Discussion
Vibrational spectroscopy has shown great promise in functional
analysis of single cells and in label-free detection of diseases [14].
Raman micro-spectroscopy is normally performed in a point to point
mapping mode, and thus is considerably slower than FTIR in imaging
mode. Nevertheless, its higher spatial and spectral resolution favours it
for cellular and subcellular analysis, rather than large scale screening of
cell populations [16,33]. Multivariate statistical techniques such as
Principal Components Analysis (PCA) and Discriminant Analysis (DA)
have significantly contributed to the development of diagnostic algo-
rithms based on the information recovered in Raman and FTIR spectral
signatures. However, before vibrational spectroscopy can be fully im-
plemented as a diagnostic platform, cross-validation with known im-
munohistochemical platforms for biomarker detection is required [34].
In this context, the current study has established for the first time that
vibrational spectroscopy can discriminate undifferentiated stem cells
Fig. 3. (a) Representative Chromatin Immunoprecipitation (ChIP) analysis of H3K4me and H4K27me3 enrichment at the Myh11 locus in freshly isolated differentiated aortic SMCs, sub-
cultured ddSMCs and bm-MSCs before and after myogenic differentiation with TGF-β1 (2 ng/ml) for 7 d. Data are the mean ± SEM of three samples and are representative of 3 similar
experiments (b) Myh11 promoter transactivation and (c) Myh11 mRNA expression levels in bm-MSCs before and after myogenic differentiation with TGF-β1 (2 ng/ml) for 2 d. Data are
the mean ± SEM of three experiments (d) representative immunocytochemical analysis of the number of Myh11+ and CNN1+ cells before and after myogenic differentiation of bm-MSC
with TGF-β1 (2 ng/ml) for 7 d, (e) CNN1 and Myh11 mRNA levels before and after myogenic differentiation with Jagged1 (2 μg/ml) for 2 d and (f) representative immunocytochemical
analysis of the number of SMA+ and CNN1+ before and after myogenic differentiation with Jag-1 (100 ng/ml) for 5 d. (g) Mean FTIR spectra and (h) scatter plot of the first principal
component after PCA for bm-MSCs before and after myogenic differentiation with TGF-β1 (2 ng/ml) and Jag-1 (2 μg/ml) for 14 d.
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from their myogenic and osteogenic progeny in vitro following valida-
tion using conventional genetic, biochemical and histological analyses.
While several studies have confirmed the accuracy of Raman spec-
troscopy in various biological tissues such as the cervical lesions, gastric
tissues, colon, thyroid, larynx, skin, bladder amongst others [14], data
on the interrogation of vascular tissue for early signs of disease have
been limited [35]. The accumulation of neointimal SMC-like cells
within the vessel wall leading to the obstruction of blood flow
represents a major hallmark of cardiovascular disease [3]. Recent
lineage tracing studies in mice and biomarker identification in human
vessels have provided compelling evidence that stem cell-derived
myogenic progeny (either directly or via endothelial-mesenchymal-
transition) in addition to de-differentiated SMCs may be responsible for
neointimal formation [4,7,9,36]. Hence the ability to discriminate de-
differentiated SMC from undifferentiated stem cells and their myogenic
and osteogenic progeny within the vessel wall and map their respective
Fig. 4. (a) Representative phase contrast images of freshly isolated aortic SMCs and St-SMCs following TGF-β1 induced myogenic differentiation. (b) Immunocytochemical analysis of
SMA and Myh11 expression and (c) quantitative qRT-PCR of Myh11 mRNA levels in freshly isolated aortic SMCs, sub-cultured ddSMCs (passage 4) and St-SMCs following TGF-β1 induced
myogenic differentiation. (d) Mean FTIR spectra and (e) a 4-way scatter plot of the first two principal components after PCA of bm-MSCs, ddSMCs, St-SMCs (TGF-β1) and St-Osteo. (f)
Mean Raman spectra and (g) a 4-way scatter plot of the first two principal components after PCA for bm-MSCs, ddSMCs, St-SMCs (TGF-β1) and St-Osteo.
Table 3
Confusion matrix for PCA-LDA of FTIR spectral data showing the percentage classification
for each cell type. Values on the diagonal represent those correctly identified, off-diagonal
values represent those incorrectly identified.
bm-MSC St-Osteo ddSMC St-SMC
bm-MSC 94 0 3 3
St-Osteo 0 100 0 0
ddSMC 7 1 92 0
St-SMC 0 0 0 100
Table 4
Confusion matrix for PCA-LDA of Raman spectral data showing the percentage classifi-
cation for each cell type. Values on the diagonal represent those correctly identified, off-
diagonal values represent those incorrectly identified.
bm-MSC St-Osteo ddSMC St-SMC
bm-MSC 100 0 0 0
St-Osteo 0 100 0 0
ddSMC 0 0 89.7 10.3
St-SMC 0 0 7.3 92.7
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accumulation over time using label-free platforms represents an at-
tractive diagnostic platform for vascular proliferative disease.
Our studies reveal for the first time that FTIR detects specific al-
terations in the cellular profile of nucleic acid, protein and lipid content
of bm-MSC when they progress towards a distinct myogenic phenotype
in vitro. Moreover, Raman further distinguished a discriminant altera-
tion in the nuclear spectra for nucleic acid, protein and lipid profiles of
these cells. These data highlight the significant screening potential of
FTIR and the more analytical potential of Raman at discriminating
undifferentiated stem cells from de-differentiated SMCs and stem cell-
derived osteogenic and myogenic progeny. Notably, the feasibility of
using prototype devices including a laser-scanning fibre endoscope
(SFE) to interrogate vascular structure in real-time in vivo and detect the
early signs of disease has been validated [35,37].
The potential of FTIR to screen cell populations and discriminate
undifferentiated stem cells from their osteogenic progeny was first es-
tablished. In particular, analysis of the FTIR spectra clearly indicated
the onset of mineralization via the emergence of the feature at
1037 cm−1 which is associated with carbonate groups in apatite
[38,39]. Interrogation of individual cell nuclei by Raman spectroscopy
further distinguished a discriminant alteration in phosphate content in
situ due to the pronounced peak at 960 cm−1 [27] that facilitated
identification of these cells from each other by PCA.
TGF-β1 is known to activate a heteromeric complex of two serine/
threonine kinase receptors [the type IITGF-β receptor (TβRII) and the
type I receptor, ALK5], that results in phosphorylation-dependent ac-
tivation of Smads 2 and 3 that subsequently complex with Smad4 and
translocate to the nucleus where they stimulate myogenic gene ex-
pression [40]. Similarly, Jag-1 binds to specific Notch receptors on the
plasma membrane that, once cleaved, act as transcriptional activators
of myogenic differentiation [41], including activation of the SMA pro-
moter [42]. Both of these stimuli promoted myogenic differentiation of
bm-MSCs in vitro by inducing specific epigenetic changes at the Myh11
promoter leading to Myh11 promoter transactivation, increased ex-
pression of transcript for SMC differentiation markers (Myh11 and
CNN1) concomitant with a significant increase in the number of
Myh11+, SMA+ and CNN1+ positive cells. Interrogation of de-differ-
entiated SMCs (ddSMCs), undifferentiated bm-MSC and their myogenic
(St-SMCs) and osteogenic progeny (St-Osteo) by FTIR revealed sig-
nificant differences in their respective spectral signatures. Notably, the
spectra associated with cellular phospholipid content of myogenic
progeny decreased when compared to undifferentiated bm-MSC
whereas there was a marked increase in levels of eCH2 symmetric and
eCH and eCH3 asymmetric stretching associated with proteins and li-
pids. This was in contrast to osteogenic differentiation where there was
a notable marked decrease in levels of eCH2 symmetric and eCH and
eCH3 asymmetric stretching. Furthermore, the similarity in the pattern
of FTIR spectral changes for both TGF-β1 and Jag-1 myogenic progeny
when compared to undifferentiated bm-MSC suggests that these dif-
ferences are independent of the inductive stimulus and were specifically
Fig. 5. (a) Mean Raman spectra and the loadings corresponding to the first two principal components for bm-MSC and the St-SMCs-TGF-β1 following myogenic differentiation. Significant
peaks in the loadings of PC1 and PC2 are highlighted and (b) corresponding scatter plot for the first two principle components for bm-MSC and the St-SMCs-TGF-β1. Mean Raman spectra
and the loadings of the first principle component and corresponding scatter plots for (c, d) bm-MSC versus ddSMCs and (e, f) ddSMCs versus St-SMC. For (c) and (d), only the first loadings
are shown, corresponding only to PC1, since separation is found in this component alone.
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associated with a myogenic inductive stimulus and response. Several
previous studies have shown a general decrease in nucleic acids in
undifferentiated cells compared to their progeny [43] while similar
changes in protein composition (e.g., α-helix structures) in stem cells
when compared to differentiated cells have been described [43,44].
More recently, FTIR spectra have been used to successfully discriminate
functional hepatocyte and chondrocyte progeny from undifferentiated
stems cells [rat bone marrow [45] murine ESCs [46] (both hepato-
cytes), and hMSCs [47](chondrocytes)] based on similar kinds of
spectral differences. As stem cell-derived myogenic progeny and de-
differentiated SMC were also separated by PCA analysis of their cor-
responding FTIR spectra, these data collectively suggest that FTIR is a
reliable platform to screen and map undifferentiated stem cell popu-
lations from their myogenic progeny. Indeed, because of the limit of
resolution, the longer wavelength of mid infrared radiation, coupled
with the use of multidetector arrays in the Fourier Transform mode,
render IR techniques very suitable for mapping larger cell populations
or tissue sections [16].
Raman spectroscopy of individual cell nuclei from undifferentiated
bm-MSC, their myogenic progeny (St-SMC-TGF-β1) and ddSMCs further
defined discrete spectral shifts in these cell populations and quantita-
tively provided reliable estimates of in situ protein, nucleic acids and
lipid content of bm-MSCs before and after myogenic and osteogenic
differentiation. Nine distinct wavenumber bands within the fingerprint
region 600–1800 cm−1 were recorded that correspond to broad bio-
chemical groupings [23,30,48]. Analysis of the spectra revealed sig-
nificant differences that facilitated further discrimination of these cell
populations by PCA. Notably, when compared to ddSMC, un-
differentiated bm-MSC had higher peaks at 785–788 cm−1 and
1585 cm−1 which are attributable to nucleic acid content. Similar
spectral differences were also observed at 785–788 cm−1 for St-SMC.
This is not surprising, as stem cells are known to have a higher nucleic
acid content than differentiated cells [49,50]. The peak at 1262 cm−1
that corresponds to nucleic acid and lipid content has also been asso-
ciated with collagen [51] and is understandably higher in the ddSMC
when compared to bm-MSC. Other notable differences for St-SMC ap-
pear at 1319 cm−1 and 1341 cm-1 and are associated with lipids, nu-
cleic acids and proteins in addition to a higher peak at 1585 cm−1
which corresponds to nucleic acids.
Importantly, there was a clear separation observed across the first
principle component for bm-MSCs and St-SMCs and for bm-MSC and
ddSMCs by FTIR suggesting that these cell populations are clearly dis-
tinct. However, interrogation by Raman across the first principle
component failed to separate these populations with 100% accuracy.
This is not unexpected since FTIR datasets are from whole cell spectra
while Raman spectra were generated exclusively from the cell nucleus.
The spectral differences within the cytoplasm may be more pronounced
as these cells begin to fate towards a myogenic lineage but still retain
significant differences within their cytoplasmic content. It is also clear
that significant epigenetic and genetic changes occur early within the
nucleus of bm-MSC as they undergo myogenic differentiation [28] and
these specific changes shared the greatest similarity with the ddSMCs.
Furthermore, since ddSMCs may be primarily derived from resident
stem cells as they grow and expand at an increased rate in culture [4], it
is not surprising that the Raman spectral profile for myogenic progeny
shared the greatest similarity with de-differentiated SMC cells. Al-
though PCA analysis did not separate the St-SMCs (TGF-β1) and ddSMC
groups with 100% accuracy, classification of both cell lines was even-
tually achieved using a combination of PCA and LDA suggesting that
there are also important differences, despite these similarities.
A primary limitation of the current study is that the bm-MSC po-
pulation were of rodent origin, heterogeneous in nature and expanded
in culture media that is different from protocols required for pre-clinical
and clinical studies. Moreover, spectral measurements were taken with
cell cultures, rather than being obtained from an intact vessel in situ.
Culturing the progeny of a single CFU or phenotype-isolated single
clonogenic human stem cell would give rise to a more homogenous
“true” human MSC population that could serve to provide similar re-
sults and further validate vibrational spectroscopic for clinical appli-
cations. Vibrational spectroscopy for ex vivo analysis of various tissues
affected by vascular diseases, including atherosclerotic plaque, vessel
wall remodelling and endothelial dysfunction has been performed [52]
[51]. The Raman spectral differences in remodelled vessels following
IMT originated mainly from the protein features within the main bands
at 1660 cm−1 (amide I), 1244 cm−1 (amide III), and at 1004 cm−1
(phenylalanine). In the spectrum of normal intimal SMCs, major bands
due to amide I (1656 cm−1), amide II (1556 cm−1), and CH bending
(1457 cm−1) vibrations of the proteins collagen and elastin have also
been reported [35,52,53]. In the spectrum of the intima of non-calcified
atherosclerotic plaque, major bands due to both proteins and lipids are
also observed. The lipid bands at 1734 cm−1, 1468 cm−1, 1171 cm−1
and 1058 cm−1 were assigned to the C = O (ester) stretch, CH2 bend,
CeO (ester) stretch and CeO stretch, respectively [35]. Our current
study suggests that St-SMCs exhibit similar enhanced spectral in-
tensities at peaks at 1004 cm−1 1451 cm−1 and 1662 cm−1 when
compared to bm-MSCs and ddSMCs respectively, suggesting that these
peak intensities might represent a specific photonic signature for stem
cell myogenic progeny that could be exploited diagnostically. Further-
more, as vascular lesions are often calcified [3], the ability to dis-
criminate between St-Osteo and St-SMCs is also an advantage. Our data
suggests that both FTIR and Raman can detect differences between
myogenic and osteogenic progeny even when they are derived from the
same undifferentiated stem cell.
In conclusion, vibrational spectroscopy was successfully applied to
the study of bm-MSCs before and after myogenic differentiation in vitro
to identify discrete spectral characteristics that could facilitate locali-
sation and detection of myogenic differentiation of resident vascular
stem cell populations in vivo. The vasculature is unique in that it has a
well-defined spatial morphology of cells either side and within the in-
ternal (IEL) and external elastic lamina (EEL) that could facilitate ac-
quisition of label-free analysis of cell spectra with relative confidence.
The initial step in the development of arteriosclerotic disease is IMT and
neointimal formation that facilitates the build-up of LDL (low density
lipoprotein) particles within the intimal layer of the vessel wall [54,55].
Interrogation of early atherosclerotic vessels in situ using vibrational
spectroscopy could discriminate the presence of stem cell-derived pro-
geny not readily available in current diagnostic imaging techniques
such as IVUS, MRI, and angiography. Indeed, significant progress has
already been made towards in vivo application of vibrational spectro-
scopy. Raman spectroscopy in particular, as an optical probe, lends it-
self naturally to endoscopic application and has recently been deployed
for intra-operative guidance of brain surgery [56] and endoscopic
gastrointestinal procedures [57]. A smart Raman needle probe has also
been developed and tested for potential in vivo and ex vivo use, capable
of measuring Raman molecular tissue signals in< 1–2 s down a hy-
podermic needle [58]. Because of its high sensitivity to water, there
have been relatively fewer in vivo applications of IR spectroscopy, al-
though the recent emergence of high brightness, tunable Quantum
Cascade Lasers has opened the door towards their development [59].
This suggests that, with further development, FTIR could provide initial
selection of cells for interrogation before quantitative chemical and
morphological evaluation by Raman discriminates these cells within
vascular lesions in situ, such as the presence of stem cell derived myo-
genic or osteogenic progeny so that more targeted therapies against
these discrete phenotypes can be introduced. Finally, circulating vas-
cular cells and progenitor cells shed from the vessel wall during IMT
and disease progression could be retrieved from blood and interrogated
for clinical evaluation using vibrational spectroscopy to provide a more
definitive tool for early diagnosis [60]. The ability to assess the accu-
mulation of stem cell-derived progeny using label free platforms in situ
or the shedding of these progeny into the blood during disease pro-
gression may further facilitate interrogation of these phenotypes by
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their discrete spectroscopic signatures using liquid biopsies and mi-
crofluidic platforms.
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